Volume 35, Issue 3 pp. E59-E64

Development and In Vitro Characterization of a New Artificial Flow Channel

Daniel Wendt

Corresponding Author

Daniel Wendt

Department of Thoracic and Cardiovascular Surgery, West-German Heart Center Essen, University Hospital Essen

Dr. Daniel Wendt, Department of Thoracic and Cardiovascular Surgery, West-German Heart Center Essen, University Hospital Essen, Hufelandstraße 55, 45122 Essen, Germany. E-mail: [email protected]Search for more papers by this author
Sebastian Stühle

Sebastian Stühle

Department of Thoracic and Cardiovascular Surgery, West-German Heart Center Essen, University Hospital Essen

University of Duisburg-Essen, Essen, Germany

Search for more papers by this author
Guojun Hou

Guojun Hou

University of Duisburg-Essen, Essen, Germany

Search for more papers by this author
Matthias Thielmann

Matthias Thielmann

Department of Thoracic and Cardiovascular Surgery, West-German Heart Center Essen, University Hospital Essen

Search for more papers by this author
Konstantinos Tsagakis

Konstantinos Tsagakis

Department of Thoracic and Cardiovascular Surgery, West-German Heart Center Essen, University Hospital Essen

Search for more papers by this author
Hermann Wendt

Hermann Wendt

Department of Thoracic and Cardiovascular Surgery, West-German Heart Center Essen, University Hospital Essen

Search for more papers by this author
Heinz Jakob

Heinz Jakob

Department of Thoracic and Cardiovascular Surgery, West-German Heart Center Essen, University Hospital Essen

Search for more papers by this author
Wojciech Kowalczyk

Wojciech Kowalczyk

University of Duisburg-Essen, Essen, Germany

Search for more papers by this author
First published: 17 February 2011
Citations: 4

Abstract

To date, cardiac valve diseases are considered as a major public health problem and most frequently, the aortic valve is affected. To treat high-risk patients, catheter-based techniques have been developed recently, avoiding open heart surgery and/or cardiopulmonary bypass. Although these sophisticated and rapidly emerging catheter-based technologies do allow a minimally invasive treatment option of high-risk patients on the one hand, further developments and in vitro testing under physiological conditions are necessary, on the other hand, in order to further optimize them for clinical routines. Therefore, we present the concept of a new multifunctional flow channel, offering (i) the possibility of transapical access; (ii) the simulation of physiological flow conditions; and (iii) the evaluation of the fluid flow by 2D particle image velocimetry within a wide range of parameters.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.